How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency

Congenital factor XIII (FXIII) deficiency is an extremely rare bleeding disorder (RBD) with estimated prevalence of one per 2 million in the general population. The disorder causes different clinical manifestations such as intracranial hemorrhage (ICH), recurrent miscarriage, umbilical cord bleeding...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Hematol Oncol Stem Cell Res
Main Authors: Shahraki, Hojat, Dorgalaleh, Akbar, Fathi, Majid, Tabibian, Shadi, Teimourian, Shahram, Mollanoori, Hasan, khiabani, Alireza, Zaker, Farhad
Formato: Artigo
Idioma:Inglês
Publicado em: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7876424/
https://ncbi.nlm.nih.gov/pubmed/33603988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/ijhoscr.v14i4.4480
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados